Spectral profiles of cultured neuronal and glial cells derived from HRMAS 1H NMR spectroscopy

NMR in Biomedicine

Volumn 15, Issue 6, 2002, Pages 375-384

  Griffin, Julian L ^a   Bollard, Mary ^a   Nicholson, Jeremy K ^a   Bhakoo, Kishore ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cerebellar neurones; Cortical astrocytes; High resolution magic angle NMR spectroscopy; Neural metabolism; O 2A progenitors

Indexed keywords

BRAIN; CELLS; LIPIDS; MACROMOLECULES; MAGNETIC RESONANCE SPECTROSCOPY; METABOLITES; NEUROLOGY; PATHOLOGY;

NEURONES;

BIOMEDICAL ENGINEERING;

CREATINE; LIPID; N ACETYLASPARTIC ACID; SOLVENT;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN DISEASE; BRAIN FUNCTION; BRAIN NERVE CELL; CELL DAMAGE; CELL LEVEL; CELL LOSS; CELL METABOLISM; CELL SEPARATION; CELL TYPE; CEREBELLUM; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; GLIA CELL; GLIOSIS; IN VIVO STUDY; MACROMOLECULE; METABOLITE; NONHUMAN; PATTERN RECOGNITION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; STEM CELL;

AMINO ACIDS; ANIMALS; ANIMALS, NEWBORN; BIOGENIC MONOAMINES; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CEREBELLUM; CORPUS CALLOSUM; MAGNETIC RESONANCE SPECTROSCOPY; NEUROGLIA; NEURONS; PHOSPHATIDYLCHOLINES; RATS; SENSITIVITY AND SPECIFICITY; STEM CELLS;

EID: 0036792396     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.792     Document Type: Article

References (33)

1. Matthews PM, Francis G, Antel J, Arnold DL. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 1991; 41: 1251-1256.
2. De Stefano N, Matthews P, Narayanan S, Francis G, Antel J, Arnold D. Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient. Neurology 1997; 49: 1138-1141.
3. Barker PB. N-acetyl aspartate-a neuronal marker? Ann. Neurol. 2001; 49: 423-424.
4. Suhy J, Rooney WD, Goodkin DE, Capizzano AA, Soher BJ, Maudsley AA, Waubant E, Andersson PB, Weiner MW. 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS. Mult. Scler. 2000; 6: 148-155.
5. Bhakoo KK, Pearce D. In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. J. Neurochem. 2000; 74: 254-262.
6. Bhakoo KK, Williams IT, Williams SR, Gadian DG, Noble MD. Proton nuclear magnetic resonance spectroscopy of primary cells derived from nervous tissue. J. Neurochem. 1996; 66: 1254-1263.
7. Florian CL, Williams SR, Bhakoo KK, Noble MD. Regional and developmental variations in metabolite concentration in the rat brain and eye: a study using 1 H-NMR spectroscopy-NMR spectroscopy and high performance liquid chromatography. Neurochem. Res. 1996; 21: 1065-1074.
8. 13C NMR study on fluxes into the TCA cycle of neuronal and glial tumour cell lines and primary cells. Biochemie 1992; 74: 941-948.
9. Urenjak J, Williams SR, Gadian DG, Noble M. Specific expression of N-acetyl-aspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J. Neurochem. 1992; 59: 55-61.
10. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 1993; 13: 981-998.
11. Millis K, Maas WE, Cory DG, Singer S. Gradient high resolution magic angle spinning nucelar magnetic resonance spectroscopy of human adipocyte tissue. Magn. Reson. Med. 1997; 38: 399-403.
12. Cheng LL, Ma MJ, Becerra L, Hale T, Tracey I, Lackner A, Gonzalez RG. Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. Proc. Natl. Acad. Sci. USA 1997; 94: 6408-6413.
13. Tomlins A, Foxall PJD, Lindon JC, Lynch MJ, Spraul M, Everett J, Nicholson JK. High resolution magic angle spinning 1 H nuclear magnetic resonance analysis of intact prostatic hyperplastic and tumour tissue. Anal. Commun. 1998; 35: 113-115.
14. Griffin JL, Williams HJ, Sang E, Niholson JK. Abnormal lipid profile of dystrophic cardiac tissue as demonstrated by one and two dimensional magic angle spinning 1H NMR spectroscopy. Magn. Reson. Med. 2001; 46: 249-255.
15. Andrew ER, Bradbury A, Eades RG. Removal of dipolar broadening of NMR spectra of solids by specimen rotation. Nature 1959; 183: 1802.
16. Mayer M, Bhakoo K, Noble M. Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 1994; 120: 143-153.
17. Bartlett PF, Noble MD, Pruss RM, Raff MC, Rattray S, Williams CA. (1980) Rat neural antigen-2 (RAN-2): a cell surface antigen on astrocytes, ependymal cells, Muller cells and lepto-meninges defined by a monoclonal antibody. Brain Res. 1980; 204: 339-351.
18. Ranscht B, Clapshaw PA, Price J, Noble M, Seifert W. Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc. Natl Acad. Sci. USA 1982; 79: 2709-2713.
19. Eisenbarth GS, Walsh FS, Nirenberg M. Monoclonal antibody to a plasma membrane antigen of neurons. Proc. Natl Acad. Sci. USA 1979; 76: 4913-4917.
20. Bogler O, Wren D, Barnett SC, Land H, Noble M. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc. Natl Acad. Sci. USA 1990; 87: 6368-6372.
21. Wood JN, Anderton BH. Monoclonal antibodies to mammalian neurofilaments. Biosci. Rep. 1981; 1: 263-268.
22. Basha G, Yap F, Penninckx F. Comparative study of classical, colorimetric, and immunologic staining methods for the assessment of tumor cell viability. Tumour Biol. 1996; 17: 354-361.
23. 1H nuclear magnetic resonance spectroscopy of intact cells. Magn. Reson. Med. 1998; 39: 337-344.
24. Holmes E et al. The identification of novel biomarkers of renal toxicity using automated data reduction techniques and PCA of proton NMR spectra of urine. Chemometrics Intelligent Lab. Syst. 1998; 44: 245-255.
25. Moka D, Vorreuther R, Schicha H, Spraul M, Humpfer E, Lipinski M, Foxall PJD, Nicholson JK, Lindon JC. Biochemical classification of kidney carcinoma biopsy samples using magic-angle-spinning 1 H nuclear magnetic resonance spectroscopy. J. Pharm. Biomed. Anal. 1998; 17: 125-137.
26. Millis M, Weybright P, Campbell N, Fletcher JA, Fletcher CD, Cory DG, Singer S. Classification of human liposarcoma and lipoma using ex vivo proton NMR spectroscopy. Magn. Reson. Med. 1999; 41: 257-267.
27. 1H NMR spectroscopic studies on intact rat renal cortex and medulla. Magn. Reson. Med. 1999; 41: 1108-1118.
28. Griffin JL, Walker LA, Troke J, Osborn D, Shore RF, Nicholson JK. The initial pathogenesis of cadmium induced renal toxicity. FEBS Letts 2000; 478: 147-150.
29. 3+) toxicity. Xenobiotica 2001; 31: 377-385.
30. 1H NMR spectra of the rat brain. J. Magn. Reson. 1999; 141: 104-120.
31. 1H NMR spectroscopy. FEBS Letts 2000; 486: 225-229.
32. Blankenberg FG, Katsikis PD, Storrs RW, Beaulieu C, Spielman D, Chen JY, Naumovski L, Tait JF. Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. Blood 1997; 89(10): 3378-3786.
33. 1H NMR visible lipids in the life and death of cells. Trends Biochem. Sci. 2000; 25(8): 357-362.